Latest

Vaccines and AMR: Strengthening the Fight

To coincide with World Immunization Week, IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.

Pharm Exec's Emerging Pharma Leaders 2018 Call for Nominations

Read more for details of how to nominate a colleague or yourself for Pharm Exec's Emerging Pharma Leaders 2018.

Patient Adherence and Human Nature

We need to look to behavioral science to deconstruct the psychological barriers that make patients act in ways that can seem irrational and self-defeating, writes Jim O'Donoghue.

South Florida Delivers on Pharma-Friendly Distribution

This article discusses the supply chain benefits of pharma companies distributing from South Florida.

PharmExec Videos

New & Noteworthy

Atopic Dermatitis — Going Beyond the Pill

There is a real opportunity for pharma to support the under-served population of atopic dermatitis patients, writes Mariel Metcalfe.

3 Behavioral Biases that Stunt the Potential of Marketers

As marketers mine for insights, they need to be keenly aware of the behavioral biases that can undermine their efforts, writes Kunsan Kim.

Rewriting Pharma’s Talent Blueprint

Amid rapid shifts in technology and consumer engagement, Lisa Henderson explores how new models in hiring and recruitment are reshaping biopharma’s future talent path.

Planning for Post-Deal Integration

Jo Pisani and Cynthia Chan outline the key legal considerations for post-deal integration.

HEOR Education: Evolving the Skill Set

Practitioners in the field of HEOR training and education outline how the best courses are responding to advancing industry needs. Julian Upton reports.

Sales & Marketing

3 Behavioral Biases that Stunt the Potential of Marketers

As marketers mine for insights, they need to be keenly aware of the behavioral biases that can undermine their efforts, writes Kunsan Kim.

Improving Persistence: Brand Team Dos and Don'ts

In Part 4 of a 4-part series on brand teams, this article discusses the tactics brand teams and partners should follow to improve medication and persistence.

Drug Marketing and Advertising Under Fire

FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

Cognitive Pharmacovigilance Intake—Elementary My Dear Watson? Not So Fast

This blog post focuses on digital process automation challenges of PV Intake, with an emphasis on the elements required to fully process an ICSR and influence upstream adverse event case processing (AECP) through the application of digital automation.

Biosimilars in China

Jin Zhang discusses the research and development of several major biologics in China.

Moving Scientists from the Lab to the Executive Suite

This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.

The New Talent Trajectory

Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.

Compliance Top of Mind

There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.
 

Read More.

Interviews

Vaccines and AMR: Strengthening the Fight

To coincide with World Immunization Week, IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.

HBA's Woman of the Year 2018

Julie Gerberding, this year's Healthcare Businesswomen’s Association Woman of the Year, has remained steadfast in her life’s mission—help the many, help the one.

Growth in the Time of Brexit: James Burt, Accord Healthcare

James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.

Regulatory

Drug Marketing and Advertising Under Fire

FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion. Jill Wechsler reports.

Mega Budget Bill Boosts Funding for Biomedical Research, FDA programs

After months of delay, Congress finally passed a $1.3 trillion omnibus budget bill March 22, 2018, just in time to avoid another government shut-down.

FDA’s Gottlieb Hits Innovators, Insurers for Blocking Biosimilar Uptake

As part of FDA initiatives to reward innovation and promote patient access to medicines, the agency is working hard to support the development of high quality biosimilars and interchangeable products, Scott Gottlieb told a conference on March 7.

From the Editor

The New Talent Trajectory

Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.

The Law of Unintended Consequences

Tackling some of the unintended consequences associated with value-based contracting in pharma and efforts to advance toward sustainable outcomes-based engagement.

lorem ipsum